Price to Earning ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PE
Period Ending - Dec-22
Excellent PE
1.27
Period Ending - Dec-21
Very Poor PE
-96.76
Growth
101.31 %
Trailing Twelve Months PE
Period Ending - Dec-22
Excellent PE
1.96
PE Analysis of Eagle Pharmaceuticals Inc
| P/E Ratio 1.96 of Eagle Pharmaceuticals Inc shows that stock price is low compared to company earnings and may be undervalued. |
| PE Ratio of EGRX rose handsomely by 101.31 % this year. |
| PE Ratio with value of 3.99 was highest in Year Dec-20 in last Five Years. |
| PE Ratio with value of -96.76 was lowest in Year Dec-21 in last Five Years. |
| Latest PE Ratio with value of 1.27 is Greater than Average PE of -17.28 in last five years. |
Other PE Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| EGRX | 3.47 | 3.425 | 1.31 % | Drug Manufacturers-Specialty & Generic |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Good Value | |
FY - Historical Price to Earning of Eagle Pharmaceuticals Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| PE | 1.27 | -96.76 | 3.99 | 3.43 | 1.66 | 1.06 | 0.700 |
| Change | 101.31 % | -2527.45 % | 16.28 % | 106.27 % | 56.37 % | 51.79 % | -96.81 % |
FY Chart of Price to Earning of Eagle Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)